Molecular diagnostics company Mylab Discovery Solutions, which launched India's first indigenously-developed RT-PCR test kit for Covid-19, is ready to join hands with the Indian Council of Medical Research (ICMR) to make diagnostic kits for the monkeypox virus, people in the know said.ICMR--India's top health research centre--had last week invited expression of interest (EoI) from vaccine manufacturers to develop a vaccine against monkeypox. Manufacturers of diagnostic kits were also asked to re

The drug firm has embarked on the digital transformation of the value chain across functions, including finance, R&D, manufacturing, supply chain, HR, customer outreach and stakeholder engagement, she added.

The National Technical Advisory Group on Immunisation (NTAGI) which reviewed the data of Corbevax earlier had found significant antibody response when it was given as a third dose to those who have received two doses of Covishield and covaxin.

Typically, bed charges constitute approximately 10-12% of average medical expenditure for hospitalisation in for-profit hospitals, said Mythri Macherla, assistant vice president and sector head at ICRA. In the absence of input tax credit, we expect the hospitals to pass on the levy to patients, making it largely credit-neutral for hospitals. However, given that in most cases, hospitals tend to offer packages for various treatments, computing bed cost separately is likely to be a challenge and cl

Monkeypox can spread from close physical contact regardless of sexual orientation or race and scapegoating or demonising the entire LGBTQ community as 'spreaders' will be a repeat of the mistake made during the AIDS epidemic, say experts

In the said circular, a specific request had been made to the subordinate police not to intervene with the practice of registered practitioners of Siddha, Ayurveda, Unani and Homeopathy and Naturopathy, who are registered with the TN Siddha Medical Council, TN Board of Indian Medicine and TN Homeopathy Medical Council.

According to a press release issued by the state government, the expansion is primarily targeted to ramp up the manufacturing of vaccines along with generic Injectables and R&D. The announcement was made after IT and Industries Minister KT Rama Rao's meeting with leadership of Biological E Mahima Datla, Managing Director.

For the first time there will be an Indian HPV vaccine to treat cervical cancer in women that is both affordable and accessible, Adar Poonawalla, CEO, SII tweeted. He said that the company will launch it later this year.